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A recurrent emerging theme is the targeting of proteins to subcellular
microdomains within bacterial cells, particularly to the poles. In most
cases, it has been assumed that this localization is critical to the
protein’s function. Legionella pneumophila uses a type IVB secretion
system (T4BSS) to export a large number of protein substrates into
the cytoplasm of host cells. Here we show that the Legionella export
apparatus is localized to the bacterial poles, as is consistent with
many T4SS substrates being retained on the phagosomal membrane
adjacent to the poles of the bacterium. More significantly, we were
able to demonstrate that polar secretion of substrates is critically re-
quired for Legionella’s alteration of the host endocytic pathway, an
activity required for this pathogen’s virulence.
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For a long time, bacteria were considered to lack subcellularstructures and to function simply as vessels for macromole-
cules such as DNA and protein. With improved technology,
specifically better microscopes, an ever-increasing number of
proteins have been localized to subdomains within bacterial cells
(reviewed in refs. 1–4). The two most notable examples of sub-
cellular domains within rod-shaped bacteria are the midcell and
the poles. Because bacteria division occurs in the middle of the
cell, cell-division proteins, most notably FtsZ, are spatially re-
stricted to the midcell. Conversely, an even larger number of
proteins are localized to the extremities of bacterial cells and are
involved in a wide variety of processes including adhesion, mo-
tility, chemotaxis, and cell differentiation (4).
In addition to these functions, many specialized secretion sys-
tems of Gram-negative pathogens are found at the bacterial poles.
These include components of the Vibrio cholerae type II secretion
system (T2SS), which are restricted to a single pole, resulting in
targeted export of substrates from that end of the cell (5). Similarly,
the Salmonella type III secretion system (T3SS) SPI-2 is found only
at the bacterial extremities (6). Although the Shigella T3SS was
observed to be distributed diffusely over the surface of the cell, the
translocon component IpaC was present at only one pole during
epithelial cell invasion (7). In addition to these secretion systems, a
number of type IV secretion systems (T4SSs) are situated at the
bacterial poles. For example, components of a T4SS in Coxiella
burnetii are polarly localized, as is the Agrobacterium tumefaciens
VirB T4SS (8–10), although the latter has also been reported to be
in helical arrays that extend from the poles (11). Furthermore,
many T5SS substrates, including Shigella flexneri IcsA, diffusely
adherent Escherichia coli AIDA-I, and Bordetella pertussis BrkA,
are confined to a single bacterial pole (12, 13). Moreover, some
Gram-positive bacteria also exhibit subcellular localization of their
secretion systems. Streptococcus pyogenes exports proteins through
a single microdomain called the “Ex-Portal” (14), and the Myco-
bacterium T7SS is found at the poles (15, 16).
Therefore, targeted export from specific domains of bacteria is a
conserved feature in many Gram-positive and Gram-negative bac-
teria. Although polar localization of bacterial secretion systems is
commonly observed, the significance of this localization remains
unconfirmed. Specifically, it is not known whether the poles simply
serve as a convenient subdomain for the assembly of multiprotein
complexes, whether secretion complexes need to be located at
the poles to function properly, or, perhaps more interestingly,
whether substrates must be exported from one or both poles.
To address these questions, we focused our attention on the
Dot/Icm (defect in organelle trafficking/intracellular multiplica-
tion) type IVB secretion system of the pathogenic bacterium
Legionella pneumophila (17, 18). This remarkable system has
been the subject of intense study, because it injects a vast rep-
ertoire of effectors, perhaps more than 300 proteins, into the
bacterial host cell (reviewed in ref. 19). These T4SS substrates
function to prevent phagosome–lysosome fusion and mediate the
recruitment of endoplasmic reticulum to the Legionella-con-
taining vacuole (LCV), thereby allowing the formation of a
unique intracellular compartment in which the bacteria grow.
Strikingly, a number of secreted Dot/Icm substrates are retained
on the cytoplasmic face of the phagosomal membrane, adja-
cent to the poles of the bacteria (20–23), suggesting that the
L. pneumophila Dot/Icm system is located at the bacterial
poles. However, it is not known if polar secretion of Dot/Icm
substrates is required to mediate survival and replication of
Legionella within normally bactericidal host cells.
Results
The Dot/Icm T4SS Is Located at the Bacterial Poles. To test the hy-
pothesis that polar secretion is the result of the location of the
T4SS, we probed stationary-phase cells using antibodies that
recognize several Dot/Icm proteins (DotH, DotG, and DotF)
that form part of the Legionella T4BSS core complex (24). A
Dot-specific signal could be detected at both bacterial poles
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in the majority of wild-type Legionella cells (Fig. 1A). The
immunofluorescence signal was specific to each protein, because
it was not present in strains lacking the corresponding gene (Fig.
1A). Polar localization was not restricted to these Dot/Icm pro-
teins, because bipolar localization of 10 additional Dot/Icm
proteins could be detected, as is consistent with previous ob-
servations showing polar localization of DotL and IcmW (22)
and several epitope-tagged Dot/Icm proteins (25). Our locali-
zation of the Dot/Icm proteins was not artificially generated,
because we assayed wild-type proteins expressed at native levels
from the chromosome. In addition, we did not use GFP fusions,
which have been reported sometimes to mislocalize to the poles
if overexpressed in bacteria (26). Finally, we were able to detect
several control proteins correctly at their natural nonpolar lo-
cation (Fig. S1), suggesting that the polar localization signal we
detected for the Dot/Icm proteins was authentic.
To corroborate the localization of the Dot/Icm proteins using
an independent method, we reexamined intact L. pneumophila
cells by electron cryotomography (ECT) (27, 28). Consistent with
our immunofluorescence data, we could observe an electron-
dense structure present at each pole between the inner and
outer membranes of wild-type cells (Fig. S2 A–D). The structure
was dependent on the Dot/Icm system, because it was absent in a
strain lacking all dot/icm genes (Fig. S2E and Movie S1). In most
cases, we could observe multiple structures at each pole (Fig. S2
and Movie S2), and careful examination of cryotomograms of
∼100 poles revealed that L. pneumophila contains an average of
4.2 Dot/Icm complexes per pole.
Based on the in vitro localization of the L. pneumophila T4SS,
we hypothesized that exported Dot/Icm substrates could be de-
tected in the cytoplasm of host cells adjacent to the bacterial
poles. To test this theory, we examined the spatial relationship
between a Dot protein (DotG) and a secreted substrate (SdeC)
within Legionella-infected mouse bone marrow-derived macro-
phages (BMMs). Because our anti-DotG and anti-T4SS substrate
antibodies were raised in rabbits, we used a L. pneumophila strain
expressing DotG fused to an epitope tag. The tagged version of
DotG fully complemented a ΔdotG mutant for intracellular
growth and appropriately colocalized with DotH and DotF within
L. pneumophila cells (Fig. S3). As predicted, the secreted
L. pneumophila T4SS substrate SdeC was present in the host cyto-
plasm adjacent to DotG-HA at both poles of the bacterium (Fig. 1B)
(21), indicating that polar export of substrates during infection is
mediated by the specific localization of the Dot/Icm secretion system.
Polar Localization of T4SS Is Linked with Cell Division. To explore the
importance of this localization, we began our investigation by
examining how the apparatus is targeted to the bacterial poles.
Although DotF localized specifically to both poles of stationary-
phase cells (Fig. 1A), exponential L. pneumophila cells displayed
a more complex pattern (Fig. 2 A–C). Smaller exponential cells,
like stationary-phase cells, had bipolar DotF staining (Fig. 2 B, i
and ii), whereas cells that had undergone elongation before di-
vision displayed an additional, third focus of DotF in the cell
center (Fig. 2 B, iii). In larger exponential cells that were likely in
the process of finishing cell division, two foci of DotF became
apparent in the cell center (Fig. 2 B, iv). Analysis of 200 cells
confirmed that shorter cells had two foci of Dot staining,
intermediate-sized cells had three foci, and larger cells had four
foci (Fig. 2D), as is consistent with the notion that initial tar-
geting of DotF occurs at the midcell. Concordant with this idea,
we detected Dot/Icm-dependent structures by ECT that were in
the bacterial cell envelope near the division plane of dividing
cells (Fig. S4 and Movie S3).
Because a newly formed pole of a rod-shaped bacterium is
generated from the division septum, the Dot/Icm complex could
accomplish polar localization by being targeted to the midcell
during cell division or by being targeted to a newly formed pole
after cell division has been completed. To confirm that Legion-
ella used the former mechanism, we examined T4SS localization
in bacterial filaments generated by inhibiting a late cell-division
protein, FtsI, that is necessary for the completion of septum
formation (29). Treatment of Legionella cells with aztreonam, an
FtsI inhibitor, generated filaments that do not contain septa
between the individual cell units (Fig. S5). Notably, these fila-
ments possessed DotF at periodic points along the filament (Fig.
2E), indicating that DotF was being targeted to the future site of
division and ruling out the possibility that targeting occurred
after the completion of cell division. We were able to observe a
similar result for both DotF and DotH using a different FtsI
inhibitor, cephalexin (Fig. S5).
The linkage of T4SS localization to cell division suggests that
the physical mechanism for targeting may likewise be dependent
on the cell-division machinery. To investigate this hypothesis, we
examined filaments created by the depletion of FtsZ, the protein
responsible for the first committed step in bacterial cell division.
In contrast to the FtsI-inhibited filaments, FtsZ depletion gen-
erated filaments with defined foci of Dot protein only at the cell
poles (Fig. 2F). Thus, the Dot/Icm T4SS complex achieves polar
localization via a component that is present and/or functions
between the action of FtsZ and FtsI during cell division.
Polar Localization Is Critical for Legionella Virulence. Because a de-
tailed molecular mechanism by which the Dot/Icm complex
targets to the poles is not yet known, we undertook an alternative
approach to studying the importance of polar localization by
changing the morphology of the cell. Rod-shaped bacterial cells
can be converted into spherical cells by exposing them to the
small molecule A22 [S-(3,4-dichlorobenzyl) isothiourea], which
Fig. 1. Bipolar localization of the Dot/Icm T4SS. (A) Broth-grown wild-type
L. pneumophila cells were harvested in stationary phase and stained with
antibodies specific to DotH, DotG, or DotF (green) and DAPI (blue). The far
right column consists of merged images of the data for the respective dot
deletions. The percentage of cells having bipolar localization of the Dot/Icm
T4SS are shown at the right with the data presented as means ± SEM from
three independent experiments in which at least 100 cells were scored in
each experiment. (B) L. pneumophila-infected macrophages were stained
with antibodies specific to DotG-HA (green), the T4SS substrate SdeC (red),
and DAPI (blue). Arrows indicate the location of DotG, and arrowheads show
secreted SdeC. b, bacteria; n, macrophage nucleus. The far right panel shows
a schematic of the data shown in the other panels. (Scale bar: 2 μm.)
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inactivates the bacterial cytoskeletal component MreB (30). As
in E. coli and Caulobacter, A22 treatment of L. pneumophila
resulted in a mixed population of cells with altered cell morphology.
Rod-shaped L. pneumophila cells first became amorphous struc-
tures, which we referred to as “UFO-shaped cells,” before becom-
ing round (Fig. 3). The morphological change of L. pneumophila
cells by A22 was both dose dependent (Fig. 3A) and time de-
pendent (Fig. 3B) and resulted in a mixed population consisting of
equal numbers of rods, UFOs, and cocci. A22 treatment also had a
pronounced effect on the localization of the Dot/Icm apparatus
(Fig. 3) when the Dot proteins were completely delocalized in
round cells (Fig. 3C, Inset for DotF). As a result, we were able to
alter the natural localization of the L. pneumophila T4SS by
inhibiting MreB function, similar to the effect seen for the polarly
localized Shigella IcsA protein (31).
This result allowed us to test if polar localization was impor-
tant for L. pneumophila virulence by examining whether A22-
treated cells could properly target the LCV to avoid the endo-
cytic pathway. As previously described (32), the majority of
LCVs containing the wild-type L. pneumophila strain Lp02 were
able to avoid colocalization with the endocytic marker LAMP-1,
whereas more than 90% of the LCVs with the dotA-deficient
strain Lp03 were LAMP-1+ (Fig. 3D). A22-treated cells that
remained rodlike were still able to prevent phagosome–lysosome
fusion at levels equal to untreated cells (only 26% LAMP-1+). In
contrast, LCVs containing UFO-shaped cells were significantly
defective in the avoidance of LAMP-1 (∼60% LAMP-1+),
whereas LCVs containing cocci-shaped cells almost always
colocalized with LAMP-1 (∼90% LAMP-1+) (Fig. 3D). Thus,
A22 treatment of L. pneumophila altered the localization of the
Dot/Icm complex and resulted in a dramatic defect in the
pathogen’s ability to alter the host’s endocytic pathway.
Because these results were generated using a drug, it was pos-
sible that the change in T4SS localization was not directly
responsible for the mistargeting of the LCV. For example,
A22 might have had an indirect effect on protein synthesis, per-
haps by preventing the expression of T4SS substrates normally
expressed in the early stationary phase. We excluded this possi-
bility by demonstrating that A22-treated UFO-shaped cells were
able to express a number of T4SS substrates and remained capable
of expressing GFP from an inducible promoter (Fig. S6). An al-
ternative explanation for the result of our A22 treatment was that
altered cell shape, rather than nonpolar localization of the T4SS,
caused the mutant LCV to fail to form a replicative phagosome.
Although we currently are unable to eliminate this possibility
completely, we do know that long filaments generated by de-
pleting FtsZ are still competent to alter the endocytic pathway of
host cells (Fig. S7), implying that cell shape per se is not critical to
the intracellular growth of L. pneumophila as long as the cells
retain polar T4SS complexes.
Fig. 2. The Dot/Icm T4SS is targeted to the poles by first localizing to the midcell of exponentially growing cells. (A) L. pneumophila cells were harvested at
exponential-growth phase and were stained with a DotF antibody (green). (B) Representative cells of increasing length from A are shown under higher mag-
nification. (C) ImageJ analysis of fluorescence intensity along the axis of the corresponding cells in B. (D) Quantitation of the number of Dot foci as a function of
cell length. A total of 200 cells were analyzed with ImageJ; data are presented as means ± SEM; asterisks indicate a statistically significant difference (P < 0.05) by
Student’s t test. (E) Filaments generated by growing L. pneumophila in the absence (0 h) or presence (8 h) of the FtsI inhibitor aztreonam were stained with the
DotF antibody (green). (F, Left and Center) L. pneumophila filaments generated by depletion of FtsZ. Cells containing isopropyl β-d-1-thiogalactopyranoside
(IPTG)-regulated ftsZwere grown in the presence (wild type) or absence (FtsZ-depleted) of IPTG and thenwere stained with an antibody to detect FtsZ (green) and
DAPI (blue). (Right) FtsZ-depleted cells were stained with an antibody to DotG (green). (Scale bars: 1 μm in B and 2 μm in A, E, and F.)









Polar Secretion of T4SS Substrates Is Required for Replication Within
Host Cells. Based on these results, we hypothesized that LCVs
containing cells with nonpolar T4SS complexes failed to avoid
the host’s endocytic pathway because they were nonfunctional,
perhaps because of their improper assembly. To test if these Dot/
Icm complexes were unable to secrete proteins, we repeated the
macrophage infections using A22-treated cells and simulta-
neously scored the LCVs for LAMP-1 colocalization and the
presence of the exported substrate SdeC. Similar to wild-type
cells, the majority of LCVs with rod-shaped L. pneumophila
cells avoided the endocytic pathway (i.e., were LAMP-1−) and
displayed SdeC on their surface (Fig. 4). In contrast, a large
number of LCVs with UFO-shaped L. pneumophila cells were
LAMP-1+, but most were secretion competent (Fig. 4). Even
more striking, almost all the LCVs with coccus-shaped bacteria
contained SdeC on their surface but were LAMP-1+ (Fig. 4).
This phenotype is unprecedented, because LCVs that mistarget
into the endocytic pathway (e.g., dot/icm mutants) have never
been shown to export Dot/Icm substrates (19). The result was not
specific to SdeC, because similar results were obtained for two
other effectors, LidA and SidC (Fig. S8 A and B), and in each
case we did not detect a significant decrease in the amount of
exported substrate (Fig. S8C). Proper translocation of the T4SS
substrates into the host cytoplasm, rather than aberrant secretion
of protein into the lumen of the LCV, was confirmed by differ-
ential permeabilization using methanol (Fig. S9). Moreover, the
Fig. 3. Bipolar localization of the Dot/Icm T4SS is necessary for alteration of the endocytic pathway by L. pneumophila. (A) Exponentially growing L. pneu-
mophila was treated with a range of the MreB inhibitor A22, followed by 6 h of growth, and then was viewed by phase-contrast microscopy. (B) L. pneumophila
was treated with 1 μg/mL of A22 for 2, 4, or 6 h. (C) Bacterial cells were untreated or were treated with A22 and stained with antibodies to DotH, DotG, or DotF.
Displayed are phase-contrast (labeled “phase”) and immunofluorescence (labeled “IF”) images. The arrows indicate representative cells whose images are en-
larged in the Insets. (D) Macrophages were infected with wild-type L. pneumophila (Lp02), a dotA mutant (Lp03), and A22-treated L. pneumophila of various
shapes (rod, UFO, and cocci) and were stained with antibodies for Legionella (red) and LAMP-1 (green). Arrows indicate the position of the LCV. The percentages
of various types of LAMP-1+ cells of are shown to the right and were obtained from three independent experiments, each consisting of 100–200 cells. Data are
presented as means ± SEM. Means with different superscript letters differ significantly by one-way ANOVA; P < 0.05. (Scale bars: 2 μm.)
Fig. 4. Polar export of T4SS substrates is required for the proper targeting of the LCV. (A) Macrophages infected with L. pneumophila having a modified cell
shape were fixed and stained with antibodies to LAMP-1 (green) and the secreted effector SdeC (red) or DAPI (blue). Shown are a LAMP−/secretion+ rod-
shaped cell and LAMP+/secretion+ UFO-shaped and round cells. (B) Phagosomes were scored for colocalization with LAMP-1 and/or secreted SdeC. Results are
shown for three independent experiments; at least 75 cells of different shapes were scored in each experiment. Data are presented as means ± SEM. Asterisks
indicate a statistical difference (P < 0.05) of each category of UFO-shaped or cocci cells compared with rod cells by Student’s t test. (Scale bar: 2 μm.)
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result was not caused by an indirect effect of the drug because it
could be phenocopied using L. pneumophila cells lacking bolA, a
gene involved in cell shape in Gram-negative bacteria (Fig. S10).
Thus, polar secretion of T4SS substrates is absolutely required
for this pathogen to replicate within host cells.
Discussion
Based on previous observations that a number of Dot/Icm-
secreted effectors localize to the cytoplasmic face of the LCV
adjacent to the bacterial poles, we hypothesized and then showed
that components of the Dot/Icm T4SS localize to both bacterial
poles and also demonstrated that the substrate SdeC was exported
juxtaposed to the poles of the bacterium during an infection. Al-
though a detailed mechanism by which Dot/Icm is localized to the
cell termini remains to be elucidated, the localization appears to
be initiated by targeting components of the T4SS to the bacterial
midcell during cell division. Finally, and most significantly, we
demonstrated that altering the shape of Legionella cells resulted in
nonpolar secretion of Dot/Icm effectors that was insufficient to
alter the host’s endocytic pathway, thereby showing that polar
secretion of substrates is required for Legionella’s virulence.
A number of mechanisms have been proposed to explain how
bacteria target proteins to their poles (2, 4). The most common
mechanism is based on a “diffusion and capture” mechanism
whereby proteins diffuse within the cell, encounter a factor that
is already at the pole, and then become trapped at that location.
Proteins that are independently targeted to the pole have been
described as “anchor” or “landmark” proteins, and their locali-
zation can occur by several different mechanisms. Some proteins
can exploit unique features of the poles of rod-shaped bacteria,
including enhanced negative curvature, altered lipid composi-
tion, and/or a more stable peptidoglycan, to be localized directly
to those subcellular domains (4). For example, Bacillus subtilis
DivIVA localizes to the poles via its specific recognition of the
increased negative curvature of the membrane (33). Similarly,
the transmembrane E. coli protein ProP targets to the bacterial
ends via its affinity for the anionic phospholipid cardiolipin,
which is enriched at the extremities of the bacterial cell (34). A
second strategy for polar localization, exhibited by some che-
moreceptor arrays, is based on their ability to self-assemble into
large complexes; this self-assembly can occur spontaneously at
sites distant from the midcell, likely because of nucleoid exclu-
sion (35). A third strategy involves exploitation of the cell-
division machinery, because the division site of rod-shaped
bacteria eventually matures into two new poles. B. subtilis
DivIVA also localizes to division septa because of their concave
membrane curvature and then can recruit other proteins to the
site of cell division and future poles (33, 36).
In the case of the L. pneumophila Dot/Icm system, we prefer
the hypothesis that it is localized to the cell poles based on
some variation of the third mechanism. Although we observed
the Dot/Icm system primarily at both poles of stationary-phase
L. pneumophila cells, we could detect Dot/Icm components and a
Dot/Icm-dependent structure at newly formed septa of exponen-
tially grown cells. Based on inhibition studies, we discovered that
proper localization of this T4SS was dependent on a factor that
acts between FtsZ and FtsI during cell division. Therefore we
favor the idea that Legionella uses a cell-division protein as an
initial anchor to target the Dot/Icm proteins to the poles.
Interestingly, our ECT analysis of intact bacterial cells revealed
that on average L. pneumophila contains only approximately four
Dot/Icm structures at each pole. The limited number of secretion
complexes was somewhat surprising, given that L. pneumophila is
known to export ∼300 Dot/Icm substrates (19), and suggests a need
for a large number of secretion apparatus per cell. However, the
Dot/Icm substrates are predicted to function as toxins within the
host cell and are not anticipated to be expressed at high levels.
Consistent with this notion, it was previously determined that each
L. pneumophila cell delivers only ∼200 molecules of the Dot/Icm
substrate VipD into an infected host cell (37). Therefore it is possible
that each L. pneumophila cell may need to be capable of exporting
fewer than ∼60,000 molecules (300 effectors × 200 molecules per
cell). Considering that a single Salmonella SPI-1 T3SS can export
∼6,000 molecules of a single effector (SipA) (38) and a single fla-
gellum can export ∼20,000 flagellin molecules (39), it is feasible that
a small number of Dot/Icm complexes are sufficient for translocation
of the vast arsenal of T4SS effectors used by L. pneumophila.
Even more surprising than the limited number of Dot/Icm
complexes per cell was the observation that the nonpolar local-
ized Dot/Icm apparatus were still able to secrete effectors into
the host cell, because we had assumed that polar localization of
the Dot/Icm system would be required for its proper assembly
and activity. However, we discovered that nonpolar export of
Dot/Icm effectors was insufficient to prevent the LCV from
aberrantly entering into the endocytic pathway. To our knowl-
edge, a requirement for polar secretion has not previously been
demonstrated for a specialized secretion system. There are a
number of possible explanations why polar secretion may be
advantageous to L. pneumophila. For example, polar secretion of
substrates could result in an increased localized concentration of
certain effectors near the LCV, and such localization might be
required to achieve a critical threshold concentration necessary
for their activity. Alternatively, targeted secretion could mediate
a hierarchical display of effectors on the LCV, perhaps using
Dot/Icm substrates initially anchored to the LCV membrane via
their propensity to bind phosphatidylinositol 4-phosphate [PI(4)P]-
enriched membranes (e.g., SidM/DrrA, SidC, and SdcA) (40).
Finally, the spatiotemporal properties of the LCV may have
conferred a steric restriction whereby functional secretion oc-
curred only at the bacterial poles. Because the newly formed
LCV resembles a macropinosome (41), initial contacts between
L. pneumophila and the LCV membrane in such a “spacious
phagosome” would occur primarily at the bacterial poles, thereby
providing an evolutionary advantage to polar localization of the
secretion system. These concepts are not mutually exclusive, and
additional investigation will be required to elucidate their role in
determining why polar secretion is important to L. pneumophila
virulence. Furthermore, similar studies in other pathogens will
likely be informative regarding the overall importance of polarized
bacterial secretion systems.
In conclusion, we have shown that the L. pneumophila Dot/Icm
T4SS is present at both poles of each bacterial cell and that the
localization of a specialized secretion system to a discrete
subcellular domain is essential for the virulence of a bacterial
pathogen. Future experiments examining how this large mac-
romolecular complex accomplishes polar localization, presumably
by exploiting a component of the cell-division machinery, will
likely provide useful information about how other proteins are
targeted to the poles. Finally, further analysis of polar secretion
will likely reveal key insights about how L. pneumophila manipu-
lates host cell functions.
Experimental Procedures
Strains and Media. L. pneumophila strains were cultured in N-(2-Acetamido)-2-
aminoethanesulfonic acid (ACES) yeast extract (AYE) broth or on buffered
charcoal yeast extract (CYE) plates. All strains were constructed in Lp02, a
thymidine auxotroph of the L. pneumophila Philadelphia-I strain (42). The
media were supplemented with 100 μg/mL thymidine as needed (AYET, CYET).
All media and antibiotic concentrations for E. coli and L. pneumophila were
used as previously described (43).
Immunofluorescence Microscopy of Legionella. L. pneumophila proteins were
localized by modification of an immunofluorescence procedure previously
described for E. coli (44). In brief, 7 μL of a culture of L. pneumophila were
fixed for 5 min in 200 μL of 80% methanol, washed in PBS, and allowed to
adhere to poly-L-lysine–coated microscope slides. A lysozyme solution [3 mg
lysozyme/mL in 25 mM Tris·HCl (pH 8.0), 50 mM glucose, 10 mM EDTA] was









used to permeabilize cells. The permeabilized cells then were incubated with
primary antibodies followed by decoration with Oregon Green-conjugated
goat anti-rabbit IgG. The cells were also stained with DAPI to detect DNA
and then were viewed using an Olympus fluorescence microscope (100×
objective). Measurements of fluorescence intensity and cell length were
done using ImageJ (National Institutes of Health).
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